FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315697801> ?p ?o ?g. }

• W4315697801 endingPage "1884" @default.
• W4315697801 startingPage "1884" @default.
• W4315697801 abstract "This meta-analysis investigated the efficacies of intra-arterial chemotherapy (IAC) plus intravesical chemotherapy (IVC) versus IVC alone in patients with non-muscle-invasive bladder cancer (NMIBC), and preoperative IAC versus preoperative intravenous chemotherapy (IV) in patients with bladder cancer. We also assessed the adverse reactions (ARs) of IAC. We searched the PubMed, Embase, Cochrane Library, and Web of Science databases for English articles published before April 2021. The qualities of cohort studies and randomized controlled trials were analyzed using the Newcastle-Ottawa Scale and Cochrane risk-of-bias tool, respectively. Effect outcomes were computed by random-effects and fixed-effects models. Statistical analyses were conducted using Stata 16.0 and RevMan v5.3.0. A total of seven articles were included. The analysis revealed that IAC plus IVC significantly prolonged recurrence-free survival (RFS) (hazard ratio [HR] = 0.55, 95% confidence interval [CI] = 0.40-0.76, I2 = 0%) and progression-free survival (PFS) (HR = 0.59, 95% CI = 0.37-0.97, I2 = 0%) compared with IVC alone in NMIBC patients after transurethral resection of bladder tumor (TURBT), but had no effect on overall survival (OS), tumor recurrence interval, or tumor-specific death rate. Preoperative IAC had no significant OS benefit compared with preoperative IV in bladder cancer patients. Regarding ARs, patients treated with IAC were significantly more likely to develop grade 1-2 ARs, including nausea/vomiting (odds ratio [OR] = 26.38, 95% CI = 1.88-370.79, I2 = 78%), neutropenia (OR = 10.15, 95% CI = 3.01-34.24, I2 = 0%), hypoleukemia (OR = 5.49, 95% CI = 1.38-21.82, I2 = 26%), and increased alanine aminotransferase (OR = 12.28, 95% CI = 2.24-67.43, I2 = 0%), but there was no significant difference between grade 1-2 ARs and grade 3-4 ARs in terms of increased creatinine in patients treated with IAC. Therefore, administration of IAC plus IVC after TURBT improved RFS and PFS compared with IAC alone in patients with NMIBC. IAC was associated with mild ARs and was well tolerated by most patients." @default.
• W4315697801 created "2023-01-12" @default.
• W4315697801 creator A5014712222 @default.
• W4315697801 creator A5036846196 @default.
• W4315697801 creator A5070480830 @default.
• W4315697801 creator A5070761755 @default.
• W4315697801 creator A5091130757 @default.
• W4315697801 date "2022-01-01" @default.
• W4315697801 modified "2023-10-10" @default.
• W4315697801 title "Efficacy and adverse reactions of intra-arterial chemotherapy in patients with bladder cancer: A systematic review and meta-analysis" @default.
• W4315697801 cites W1985466857 @default.
• W4315697801 cites W1995746323 @default.
• W4315697801 cites W2008068065 @default.
• W4315697801 cites W2032275726 @default.
• W4315697801 cites W2045948475 @default.
• W4315697801 cites W2059724945 @default.
• W4315697801 cites W2079612669 @default.
• W4315697801 cites W2082632361 @default.
• W4315697801 cites W2088095316 @default.
• W4315697801 cites W2097965368 @default.
• W4315697801 cites W2098923148 @default.
• W4315697801 cites W2113156769 @default.
• W4315697801 cites W2116475791 @default.
• W4315697801 cites W2126051101 @default.
• W4315697801 cites W2134589781 @default.
• W4315697801 cites W2151575881 @default.
• W4315697801 cites W2162130153 @default.
• W4315697801 cites W2165662398 @default.
• W4315697801 cites W2166453367 @default.
• W4315697801 cites W2169205464 @default.
• W4315697801 cites W2472772591 @default.
• W4315697801 cites W2606654912 @default.
• W4315697801 cites W2793829872 @default.
• W4315697801 cites W2891930319 @default.
• W4315697801 cites W2905547223 @default.
• W4315697801 cites W2915006506 @default.
• W4315697801 cites W2924744410 @default.
• W4315697801 cites W2969983122 @default.
• W4315697801 cites W2979845453 @default.
• W4315697801 cites W2989053674 @default.
• W4315697801 cites W2990926740 @default.
• W4315697801 cites W3108159008 @default.
• W4315697801 cites W3109907134 @default.
• W4315697801 cites W3113175684 @default.
• W4315697801 cites W3128646645 @default.
• W4315697801 cites W2087996032 @default.
• W4315697801 doi "https://doi.org/10.4103/jcrt.jcrt_2187_21" @default.
• W4315697801 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36647946" @default.
• W4315697801 hasPublicationYear "2022" @default.
• W4315697801 type Work @default.
• W4315697801 citedByCount "2" @default.
• W4315697801 countsByYear W43156978012023 @default.
• W4315697801 crossrefType "journal-article" @default.
• W4315697801 hasAuthorship W4315697801A5014712222 @default.
• W4315697801 hasAuthorship W4315697801A5036846196 @default.
• W4315697801 hasAuthorship W4315697801A5070480830 @default.
• W4315697801 hasAuthorship W4315697801A5070761755 @default.
• W4315697801 hasAuthorship W4315697801A5091130757 @default.
• W4315697801 hasBestOaLocation W43156978011 @default.
• W4315697801 hasConcept C121608353 @default.
• W4315697801 hasConcept C126322002 @default.
• W4315697801 hasConcept C126894567 @default.
• W4315697801 hasConcept C141071460 @default.
• W4315697801 hasConcept C143998085 @default.
• W4315697801 hasConcept C156957248 @default.
• W4315697801 hasConcept C168563851 @default.
• W4315697801 hasConcept C197934379 @default.
• W4315697801 hasConcept C207103383 @default.
• W4315697801 hasConcept C2776478404 @default.
• W4315697801 hasConcept C2776694085 @default.
• W4315697801 hasConcept C2777063308 @default.
• W4315697801 hasConcept C2780352672 @default.
• W4315697801 hasConcept C2780580376 @default.
• W4315697801 hasConcept C44249647 @default.
• W4315697801 hasConcept C71924100 @default.
• W4315697801 hasConcept C95190672 @default.
• W4315697801 hasConceptScore W4315697801C121608353 @default.
• W4315697801 hasConceptScore W4315697801C126322002 @default.
• W4315697801 hasConceptScore W4315697801C126894567 @default.
• W4315697801 hasConceptScore W4315697801C141071460 @default.
• W4315697801 hasConceptScore W4315697801C143998085 @default.
• W4315697801 hasConceptScore W4315697801C156957248 @default.
• W4315697801 hasConceptScore W4315697801C168563851 @default.
• W4315697801 hasConceptScore W4315697801C197934379 @default.
• W4315697801 hasConceptScore W4315697801C207103383 @default.
• W4315697801 hasConceptScore W4315697801C2776478404 @default.
• W4315697801 hasConceptScore W4315697801C2776694085 @default.
• W4315697801 hasConceptScore W4315697801C2777063308 @default.
• W4315697801 hasConceptScore W4315697801C2780352672 @default.
• W4315697801 hasConceptScore W4315697801C2780580376 @default.
• W4315697801 hasConceptScore W4315697801C44249647 @default.
• W4315697801 hasConceptScore W4315697801C71924100 @default.
• W4315697801 hasConceptScore W4315697801C95190672 @default.
• W4315697801 hasIssue "7" @default.
• W4315697801 hasLocation W43156978011 @default.
• W4315697801 hasLocation W43156978012 @default.
• W4315697801 hasOpenAccess W4315697801 @default.
• W4315697801 hasPrimaryLocation W43156978011 @default.

• next